Mikael E. Eriksson

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 314 publications

PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups.

PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups.

Journal: medRxiv : the preprint server for health sciences

Published: July 29, 2026

A long-term image-derived AI-based risk model for primary prevention of breast cancer in individuals at high risk.

A long-term image-derived AI-based risk model for primary prevention of breast cancer in individuals at high risk.

Journal: Science translational medicine

Published: May 20, 2026

Parent-Led Pain Management in Neonatal Care-Time to Move Forward.

Parent-Led Pain Management in Neonatal Care-Time to Move Forward.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: April 24, 2026

Initiation of High-Potency Benzodiazepine Prescriptions Among Survivors of Severe Trauma.

Initiation of High-Potency Benzodiazepine Prescriptions Among Survivors of Severe Trauma.

Journal: Acta anaesthesiologica Scandinavica

Published: February 18, 2026

Blood DNA methylation and breast cancer risk: a prospective nested case-control study.

Blood DNA methylation and breast cancer risk: a prospective nested case-control study.

Journal: EBioMedicine

Published: February 10, 2026

Modeling Individual-Level Uncertainty From Missing Data in Multifactorial Breast Cancer Risk Prediction.

Modeling Individual-Level Uncertainty From Missing Data in Multifactorial Breast Cancer Risk Prediction.

Journal: JCO precision oncology

Published: February 06, 2026

The impact of community-acquired critical sepsis on long-term mortality and morbidity-a nationwide cohort study.

The impact of community-acquired critical sepsis on long-term mortality and morbidity-a nationwide cohort study.

Journal: Scientific reports

Published: October 19, 2025

Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trial.

Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trial.

Journal: Journal of the National Cancer Institute

Published: September 30, 2025

Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction Model.

Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction Model.

Journal: JCO precision oncology

Published: September 26, 2025

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Journal: Cancers

Published: September 09, 2025

Statins and postmenopausal breast cancer risk; results from the KARMA cohort.

Statins and postmenopausal breast cancer risk; results from the KARMA cohort.

Journal: Cancer causes & control : CCC

Published: August 18, 2025

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: July 09, 2025

Showing 1-12 of 314

Last Updated: 09/26/2026